Press release
What Factors Are Affecting The Effect of Cancer Treatment?
Unlike common diseases such as colds and coughs, cancer is a more significant disease with a high mortality rate. Globally, cancer causes the second largest number of deaths after cardiovascular disease.
What factors can affect the effectiveness of cancer treatment?
The effectiveness of cancer treatment is influenced by a number of factors, such as the type and stage of cancer (how much it has spread in the body), the type of treatment, the characteristics of the cancer cells, and the lifestyle after treatment.
Types of cancer
Cancer is a general term for a group of diseases, not a single disease, but an umbrella term for hundreds of different diseases. The basic characteristic of these diseases is uncontrolled cell growth, but each type of cancer and each person's specific cancer is unique and has its own set of problems.
Some types of cancer can be treated with excellent results, such as breast, prostate and thyroid cancers where 5-year survival rates after treatment have been 90% or higher. Some cancers still have a high mortality rate, such as pancreatic cancer, which is known as the king of cancers, and still have a low survival rate.
Cancer Staging
Usually, the earlier a cancer is detected, the less likely it is to metastasize, and the better the treatment outcome. Early stage cancers have a higher remission rate than the same type of advanced cancer. For example, early stage breast cancer, lung cancer, colorectal cancer, gastric cancer, prostate cancer, etc., are more likely to go into remission after surgery, or surgery combined with chemotherapy, radiotherapy, targeted therapy or immunotherapy than the same type of advanced cancer.
Treatment modalities
Although with medical advances, cancer treatment modalities, including surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy, have also been developed and matured. The tolerance and response of cancer patients to different treatment modalities vary, and the treatment effect of cancer can be very different.
Tolerance refers to an adaptive state and result of the body's response to drugs. If cancer patients lack tolerance to effective treatment modalities or have poor overall health, treatment causes more side effects than treatment effects, which can also lead to poorer treatment outcomes.
In addition, for certain types of cancer, such as pancreatic cancer, there is still the dilemma of difficult surgery and lack of effective adjuvant treatment.
Cancer cell characteristics
The characteristics of cancer cells in patients with the same type of cancer can be very different, including the growth rate of cancer cells, invasive ability and sensitivity to drugs. The effectiveness of cancer treatment can also vary greatly depending on the characteristics of cancer cells.
Lifestyle
Scientists believe that factors that can increase the risk of cancer may also promote the recurrence of cancer after treatment. If a healthy lifestyle is adopted after treatment, including healthy diet, regular exercise, smoking cessation and alcohol cessation, it will help prevent cancer recurrence, prolong the remission period and improve the survival rate.
Although cancer is still difficult to be completely cured, with the deepening of research and the development of medicine, people have more knowledge and understanding of cancer. Hopefully, in the near future, cancer will no longer be a phobic disease and people will be able to get better survival after treatment.
PEG is an important development in anti-cancer therapy. PEGylation has the ability to enhance the retention time of the therapeutics like proteins, which consequently improves their therapeutic potential. As a professional PEG supplier, Biochempeg can provide variety quantities of high quality functionalized PEGs, which are essential for PEGylated therapeutic proteins.
Biochempeg Scientific Inc.
108 Water Street, Room 4D, Watertown, MA 02472, USA
TEL: 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Website: https://www.biochempeg.com
Biochempeg is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity polyethylene glycol (PEG) derivatives and reagents, monodisperse PEG, Click Chemistry reagents, PEGylation services and custom PEG derivative synthesis to clients worldwide. These PEG reagents have been widely used in bioconjugation, antibody-drug conjugates (ADCs) therapeutic, drug delivery and diagnostics field.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Factors Are Affecting The Effect of Cancer Treatment? here
News-ID: 2342860 • Views: …
More Releases from Biochempeg Scientific Inc.
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
Semaglutide VS Liraglutide: Which Is Better For Weight Loss
Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in the Jan. 11 issue of the Journal of the American Medical Association.
Domenica M. Rubino, M.D., from the Washington Center for Weight Management and Research in Arlington, Virginia, and colleagues compared the efficacy and adverse event…
What Are Components And Mechanism Action of Antibody-Drug Conjugates
Antibody-Drug Conjugates (ADC) is a type of anticancer drug that links a drug to cancer-targeting antibodies. The antibody detects tumor-specific proteins expressed on cancer cells and directs the cytotoxic anticancer drug towards the cancer cell.
Compared to alternative cancer treatments, for example, chemotherapy, immunotherapy, radiation, and stem cell therapy, ADC combines chemotherapy and immunotherapy and allows selective delivery of anticancer drugs and reduces systemic exposure and toxicity of anticancer drugs.
Components of ADC
One…
Sacituzumab govitecan shows promise in treating the most aggressive type of brea …
A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time of patients with refractory metastatic triple-negative breast cancer. The study of the ADC drug sacituzumab govitecan (SG), for which Massachusetts General Hospital (MGH) was a lead clinical research site after serving as…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
